Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition

Chen Chen(Jilin University), Dongdong Fang(Shanghai University of Traditional Chinese Medicine)

Molecules

October 16, 2019

10.3390/molecules24203725

Cited by 45

Related Papers

The biology and role of CD44 in cancer progression: therapeutic implications

|Journal of Hematology & Oncology|2018|1.4k

Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells

|Nature Communications|2014|235

Insulin Receptor Trafficking: Consequences for Insulin Sensitivity and Diabetes

|International Journal of Molecular Sciences|2019|112

Autologous fibroblasts induce fibrosis of the nucleus pulposus to maintain the stability of degenerative intervertebral discs

|Bone Research|2020|69

Ubiquitin‐activating enzyme <scp>E</scp>1 inhibitor <scp>PYR</scp>41 attenuates angiotensin <scp>II</scp>‐induced activation of dendritic cells via the I<i>κ</i><scp>B</scp>a/<scp>NF</scp>‐<i>κ</i><scp>B</scp> and <scp>MKP</scp>1/<scp>ERK</scp>/<scp>STAT</scp>1 pathways

|Immunology|2014|45